MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024

Group 1 - MannKind Corporation will release its third quarter 2024 financial results after market close on November 7, 2024 [1] - A webcast to discuss the quarterly results and provide a business update will be hosted at 4:30 p.m. Eastern Time, featuring CEO Michael Castagna and CFO Chris Prentiss [2] - The webcast will be accessible on MannKind's website, with a replay available for approximately 90 days [2] Group 2 - MannKind focuses on developing and commercializing innovative inhaled therapeutic products for serious unmet medical needs, particularly in endocrine and orphan lung diseases [3] - The company aims to alleviate the burden of diseases such as diabetes, NTM lung disease, pulmonary fibrosis, and pulmonary hypertension through its formulation and device engineering capabilities [4] - MannKind's technologies include dry-powder formulations and inhalation devices that enable rapid and convenient delivery of medicines [4]